These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 39208980

  • 41. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H, Wang W, Jiang Z, Shang J, Zhang L.
    Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
    [Abstract] [Full Text] [Related]

  • 42. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA, Nguyen HQ, Smith DL, Schechter LE.
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [Abstract] [Full Text] [Related]

  • 43. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T, Umbers V, Gartside SE.
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [Abstract] [Full Text] [Related]

  • 44. Antidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonist.
    Chen HX, Jin ZL, Zhang LM, Xue R, Xu XD, Zhao N, Qiu ZK, Wang XW, Zhang YZ, Yang RF, Li YF.
    PLoS One; 2013 Jul; 8(12):e83271. PubMed ID: 24367588
    [Abstract] [Full Text] [Related]

  • 45. Cav1.2 L-type calcium channels regulate stress coping behavior via serotonin neurons.
    Ehlinger DG, Commons KG.
    Neuropharmacology; 2019 Jan; 144():282-290. PubMed ID: 30176250
    [Abstract] [Full Text] [Related]

  • 46. The postnatal 5-HT1A receptor regulates adult anxiety and depression differently via multiple molecules.
    Ishikawa C, Shiga T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug 01; 78():66-74. PubMed ID: 28483674
    [Abstract] [Full Text] [Related]

  • 47. Pharmacological MRI to investigate the functional selectivity of 5-HT1A receptor biased agonists.
    Vidal B, Bolbos R, Redouté J, Langlois JB, Costes N, Newman-Tancredi A, Zimmer L.
    Neuropharmacology; 2020 Aug 01; 172():107867. PubMed ID: 31783063
    [Abstract] [Full Text] [Related]

  • 48. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP, Mansari ME, Murphy DL, Blier P.
    Int J Neuropsychopharmacol; 2012 Apr 01; 15(3):349-61. PubMed ID: 21439106
    [Abstract] [Full Text] [Related]

  • 49. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.
    Eur Neuropsychopharmacol; 2004 Dec 01; 14(6):487-95. PubMed ID: 15589388
    [Abstract] [Full Text] [Related]

  • 50. A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain.
    Popa D, Cerdan J, Repérant C, Guiard BP, Guilloux JP, David DJ, Gardier AM.
    Eur J Pharmacol; 2010 Feb 25; 628(1-3):83-90. PubMed ID: 19944680
    [Abstract] [Full Text] [Related]

  • 51. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.
    Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P.
    Psychopharmacology (Berl); 2012 May 25; 221(2):261-72. PubMed ID: 22147258
    [Abstract] [Full Text] [Related]

  • 52. Other Antidepressants.
    Schwasinger-Schmidt TE, Macaluso M.
    Handb Exp Pharmacol; 2019 May 25; 250():325-355. PubMed ID: 30194544
    [Abstract] [Full Text] [Related]

  • 53. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM, Monge A, Del Río J, Lasheras B.
    Eur J Pharmacol; 2002 May 03; 442(1-2):63-71. PubMed ID: 12020683
    [Abstract] [Full Text] [Related]

  • 54. Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments.
    Guilloux JP, David DJ, Xia L, Nguyen HT, Rainer Q, Guiard BP, Repérant C, Deltheil T, Toth M, Hen R, Gardier AM.
    Neuropharmacology; 2011 Sep 03; 61(3):478-88. PubMed ID: 21333660
    [Abstract] [Full Text] [Related]

  • 55. CRISPR/Cas9-mediated in vivo gene editing reveals that neuronal 5-HT1A receptors in the dorsal raphe nucleus contribute to body temperature regulation in mice.
    Nishitani N, Ohmura Y, Nagayasu K, Shibui N, Kaneko S, Ohashi A, Yoshida T, Yamanaka A, Yoshioka M.
    Brain Res; 2019 Sep 15; 1719():243-252. PubMed ID: 31194947
    [Abstract] [Full Text] [Related]

  • 56. Anxiolytic effects of prelimbic 5-HT(1A) receptor activation in the hemiparkinsonian rat.
    Hui YP, Wang T, Han LN, Li LB, Sun YN, Liu J, Qiao HF, Zhang QJ.
    Behav Brain Res; 2015 Jan 15; 277():211-20. PubMed ID: 24906197
    [Abstract] [Full Text] [Related]

  • 57. Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization.
    Greene J, Banasr M, Lee B, Warner-Schmidt J, Duman RS.
    Neuropsychopharmacology; 2009 Oct 15; 34(11):2459-68. PubMed ID: 19553916
    [Abstract] [Full Text] [Related]

  • 58. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V, Cistarelli L, Gobert A.
    J Pharmacol Exp Ther; 1997 Jul 15; 282(1):132-47. PubMed ID: 9223549
    [Abstract] [Full Text] [Related]

  • 59. Serotonergically dependent antidepressant-like activity on behavior and stress axis responsivity of acacetin.
    Xiao WZ, Zhou WH, Ma Q, Cui WG, Mei QY, Zhao X.
    Pharmacol Res; 2019 Aug 15; 146():104310. PubMed ID: 31229563
    [Abstract] [Full Text] [Related]

  • 60. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J, Huang XY, Ye ML, Luo CX, Wu HY, Hu Y, Zhou QG, Wu DL, Zhu LJ, Zhu DY.
    J Neurosci; 2010 Feb 17; 30(7):2433-41. PubMed ID: 20164327
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.